SFX by Ex Libris Inc.

Title:	Gene transfer and expression of a non-viral polycation-based vector in CD4+ cells
Source:	Gene Therapy [0969-7128] Puls, R L yr:1999

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Germershaus, O. "Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors." Bioconjugate chemistry 17.5 (2006): 1190-1199.
description	2.	Chiu, Shih-Jiuan H. "Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin (R)) conjugated polyethylemmine." Journal of Controlled Release 97.2 (2004): 357-369.
description	3.	Jung, Y. "Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells." Journal of Controlled Release 123.2 (2007): 164-71.
description	4.	Steinhauser, I.. "Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells." Biomaterials 27.28 (2006): 4975-4983.
description	5.	Kim, Sun H. "Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine)." Journal of controlled release 104.1 (2005): 223-232.
description	6.	Akinc, A. "Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis." The journal of gene medicine 7.5 (2005): 657-663.
description	7.	Greenland, John R R. "beta-amino ester polymers facilitate in vivo DNA transfection and adjuvant plasmid DNA immunization." Molecular therapy 12.1 (2005): 164-170.
description	8.	Behr, Jean l. "The proton sponge. A trick to enter cells the viruses did not exploit." Chimia 51.1 (1997): 34-36.
description	9.	Vlasov, G. "Starburst conjugates of proteins with carbon-chain polymers containing low molecular biologically active compounds: Synthesis and immunogenicity." Russian journal of bioorganic chemistry 29.1 (2003): 33-42.
description	10.	Kenny, Laura M. "Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab." Clinical cancer research 16.16 (2010): 4236-4245.
description	11.	Karve, S. "The pH-dependent association with cancer cells of tunable functionalized lipid vesicles with encapsulated doxorubicin for high cell-kill selectivity." Biomaterials 31.15 (2010): 4409-4416.
description	12.	Leong, Xue-Qing W. "In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core." Biomacromolecules 6.1 (2005): 341-50.
description	13.	LEE, A. "The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles." Biomaterials 30.5 (2009): 919-927.
description	14.	De Palma, M. "Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells." Nature medicine 9.6 (2003): 789-95.
description	15.	Petersen, H. "Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines." Biomacromolecules 3.5 (2002): 926-936.
description	16.	Tang, W. "Quantitative analysis of siRNA-mediated GFP silencing in transgenic pine cells." Plant science 168.3 (2005): 741-746.
description	17.	Sancho, JM. "Comment on "Diffusion on a solid surface: Anomalous is normal" - Reply." Physical review letters 94.18 (2005).
description	18.	Kim, P. "Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin." Biomaterials 32.9 (2011): 2314-26.
description	19.	Lee, S. "Fabrication of Double-Doped Magnetic Silica Nanospheres and Deposition of Thin Gold Layer." BULLETIN OF THE KOREAN CHEMICAL SOCIETY 30.4 (2009): 869-872.
description	20.	Hayes, M E E. "Increased Target Specificity of Anti-HER2 Genospheres by Modification of Surface Charge and Degree of PEGylation." Molecular pharmaceutics 3.6: 726-36.